Untitled Document
Not a member yet? Register for full benefits!

Username
Password
 Cyberkinetics Provides Update on BrainGate System Pilot Clincal Trials

This story is from the category The Brain
Printer Friendly Version
Email to a Friend (currently Down)

 

 

Date posted: 13/02/2006

(Press Release) Cyberkinetics Neurotechnology Systems, Inc. on the eighth of February, provided a quarterly update on two pilot clinical studies currently underway of the Company's BrainGate Neural Interface System. The first trial is for those with quadriplegia due to spinal cord injury, stroke or muscular dystrophy; and the second is for those diagnosed with ALS or other motor neuron diseases
The Company reported that a total of four participants have enrolled in two pilot clinical trials, including three in the SCI trial and one in the ALS trial.

Under the terms of a five-year, $4.4 million contract awarded in 2005 by the National Center for Medical Rehabilitation Research, a component of the National Institute of Child Health and Human Development, Cyberkinetics and Case Western Reserve University and the Cleveland FES Center will combine the limb-movement electrical stimulation technology developed at Case and the FES Center with Cyberkinetics' brain-interface technology. The goal of the collaboration is to develop a neural prosthesis that enables those with quadriplegia to control their own arms and hands in a way that allows them to, for example, feed themselves.

"Over the last few months we have increased the pace of development and clinical testing of the BrainGate system significantly," said John Donoghue, Ph.D., Founder and Chief Scientific Officer of Cyberkinetics and Chairman of the Department of Neuroscience at Brown University. "What we have seen to date indicates that we are making important progress toward our goal of allowing people with severe disabilities to use the BrainGate System to operate ordinary, everyday devices simply by thinking - which could provide a greater sense of independence and control."

"The expansion of our clinical trial enrollment and the initiation of key academic partnerships have accelerated our progress toward Cyberkinetics' ultimate goal of developing a safe, effective and unobtrusive BrainGate neural interface that is designed to allow severely disabled individuals to control computers and other everyday devices using their thoughts," said Tim Surgenor, Cyberkinetics' President and Chief Executive Officer. "We look forward to reporting on the results of these efforts at scientific and medical conferences during the rest of 2006."

See the full Story via external site: www.genengnews.com



Most recent stories in this category (The Brain):

04/02/2017: HKU scientists utilise innovative neuroimaging approach to unravel complex brain networks

26/01/2017: Personality linked to 'differences in brain structure'

12/01/2017: Donkey Kong used to Help Guide New Approaches in Neuroscience

10/12/2016: Doctors use deep-brain ultrasound therapy to treat tremors

17/02/2015: Hearing experts break sound barrier for children born without hearing nerve

17/02/2015: Smoking thins vital part of brain

05/02/2015: Intracranial Stimulation Proved Efficient in the Recovery of Learning and Memory in Rats

05/02/2015: Repeated head blows linked to smaller brain volume and slower processing speeds